Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

CFMS

Conformis (CFMS)

Conformis Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:CFMS
DateHeureSourceTitreSymboleSociété
15/09/202315h56Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CFMSConformis Inc
05/09/202314h18GlobeNewswire Inc.restor3d Completes Acquisition of ConformisNASDAQ:CFMSConformis Inc
05/09/202314h14Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:CFMSConformis Inc
05/09/202312h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CFMSConformis Inc
05/09/202312h08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CFMSConformis Inc
05/09/202312h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CFMSConformis Inc
24/08/202323h04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CFMSConformis Inc
23/08/202314h00GlobeNewswire Inc.Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3dNASDAQ:CFMSConformis Inc
21/08/202322h10GlobeNewswire Inc.Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3dNASDAQ:CFMSConformis Inc
02/08/202323h22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CFMSConformis Inc
02/08/202323h15GlobeNewswire Inc.Conformis Reports Second Quarter 2023 Financial ResultsNASDAQ:CFMSConformis Inc
24/07/202314h00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CFMSConformis Inc
14/07/202322h28Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CFMSConformis Inc
26/06/202323h27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CFMSConformis Inc
23/06/202304h05GlobeNewswire Inc.Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in CashNASDAQ:CFMSConformis Inc
11/05/202323h14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CFMSConformis Inc
10/05/202322h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CFMSConformis Inc
08/05/202314h21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CFMSConformis Inc
08/05/202314h05GlobeNewswire Inc.Conformis Reports First Quarter 2023 Financial ResultsNASDAQ:CFMSConformis Inc
13/04/202322h30GlobeNewswire Inc.Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023NASDAQ:CFMSConformis Inc
24/03/202321h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CFMSConformis Inc
21/03/202312h00GlobeNewswire Inc.Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement ProceduresNASDAQ:CFMSConformis Inc
01/03/202322h19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CFMSConformis Inc
01/03/202322h05GlobeNewswire Inc.Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial ResultsNASDAQ:CFMSConformis Inc
21/02/202322h15GlobeNewswire Inc.Conformis, Inc. to Participate in Upcoming Investor ConferencesNASDAQ:CFMSConformis Inc
15/02/202322h15GlobeNewswire Inc.Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent LitigationNASDAQ:CFMSConformis Inc
10/02/202313h00GlobeNewswire Inc.Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022NASDAQ:CFMSConformis Inc
09/02/202323h29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CFMSConformis Inc
23/01/202322h30GlobeNewswire Inc.Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022NASDAQ:CFMSConformis Inc
30/11/202222h30GlobeNewswire Inc.Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:CFMSConformis Inc
 Showing the most relevant articles for your search:NASDAQ:CFMS